BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 17261787)

  • 21. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.
    Rossouw JE
    Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis.
    Phillips LS; Langer RD
    Fertil Steril; 2005 Mar; 83(3):558-66. PubMed ID: 15749481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone therapy and cardiovascular disease--still much to be learnt.
    Mikkola TS; Ylikorkala O
    Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are there second thoughts about the results of the WHI study?
    Haimov-Kochman R; Hochner-Celnikier D
    Acta Obstet Gynecol Scand; 2006; 85(4):387-93. PubMed ID: 16612699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
    Mobasseri S; Liebson PR; Klein LW
    Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].
    Gaspard U
    J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular effects of estrogen in postmenopausal women].
    Zhu WL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):409-12. PubMed ID: 12905664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC
    Maturitas; 2007 May; 57(1):31-4. PubMed ID: 17383835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal hormone therapy: have HERS2 and WHI given us any new information?
    Fylstra DL
    J S C Med Assoc; 2002 Dec; 98(8):299-304. PubMed ID: 12532655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F; Gerson M
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When is it appropriate to prescribe postmenopausal hormone therapy?
    Ettinger B; Barrett-Connor E; Hoq LA; Vader JP; Dubois RW
    Menopause; 2006; 13(3):404-10. PubMed ID: 16735937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary prevention of coronary heart disease in women.
    Rees M; Stevenson J;
    Menopause Int; 2008 Mar; 14(1):40-5. PubMed ID: 18380961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.